Perbedaan Organon Pharma Indonesia Tbk. dan Super Bank Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Super Bank Indonesia Tbk. diperdagangkan di Rp505 (kapitalisasi pasar 17,11 T, volume 24 jam 11,9 jt). Perbedaan utamanya: Super Bank Indonesia Tbk. jauh lebih besar — sekitar 163,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SUPA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 17,11 T |
Volume | — | 11,9 jt |
Lot | — | 119,04 rb |
Perputaran | — | 6 M |
Harga Rata-rata | — | 504,24 |
Nilai Transaksi | — | 6 M |
Harga Ekuilibrium Indikatif | — | 505 |
Volume Ekuilibrium Indikatif | — | 1,29 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.
Selengkapnya di halaman SUPA →